journal article·2024-04-27Open access

Cell Instructive Behavior of Composite Scaffolds in a Co-Culture of Human Mesenchymal Stem Cells and Peripheral Blood Mononuclear Cells

Georgia-Ioanna Kontogianni, Amedeo Franco Bonatti, Carmelo De Maria, Raasti Naseem, Catarina Coelho, Kalliopi Alpantaki, Aristea Batsali, Charalampos Pontikoglou, Paulo Quadros, Kenneth Dalgarno, Giovanni Vozzi, Chiara Vitale-Brovarone, Maria Chatzinikolaidou

Abstract

The in vitro evaluation of 3D scaffolds for bone tissue engineering in mono-cultures is a common practice; however, it does not represent the native complex nature of bone tissue. Co-cultures of osteoblasts and osteoclasts, without the addition of stimulating agents for monitoring cellular cross-talk, remains a challenge. In this study, a growth factor-free co-culture of human bone marrow-derived mesenchymal stem cells (hBM-MSCs) and human peripheral blood mononuclear cells (hPBMCs) has been established and used for the evaluation of 3D-printed scaffolds for bone tissue engineering. The scaffolds were produced from PLLA/PCL/PHBV polymeric blends, with two composite materials produced through the addition of 2.5% w/v nanohydroxyapatite (nHA) or strontium-substituted nanohydroxyapatite (Sr-nHA). Cell morphology data showed that hPBMCs remained undifferentiated in co-culture, while no obvious differences were observed in the mono- and co-cultures of hBM-MSCs. A significantly increased alkaline phosphatase (ALP) activity and osteogenic gene expression was observed in co-culture on Sr-nHA-containing scaffolds. Tartrate-resistant acid phosphatase (TRAP) activity and osteoclastogenic gene expression displayed significantly suppressed levels in co-culture on Sr-nHA-containing scaffolds. Interestingly, mono-cultures of hPBMCs on Sr-nHA-containing scaffolds indicated a delay in osteoclasts formation, as evidenced from TRAP activity and gene expression, demonstrating that strontium acts as an osteoclastogenesis inhibitor. This co-culture study presents an effective 3D model to evaluate the regenerative capacity of scaffolds for bone tissue engineering, thus minimizing time-consuming and costly in vivo experiments.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · 3D Printing in Biomedical Research · Orthopaedic implants and arthroplasty

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Materials Science and Engineering, University of Crete, 70013 Heraklion, Greece

Research Center E. Piaggio, Department of Information Engineering, University of Pisa, 56126 Pisa, Italy

School of Engineering, Newcastle University, Newcastle upon Tyne NE1 7RU, UK

FLUIDINOVA, S.A., 4475-188 Maia, Portugal

Department of Orthopaedics and Trauma, Venizeleion General Hospital of Heraklion, 70013 Heraklion, Greece

Hemopoiesis Research Laboratory, School of Medicine, University of Crete, 70013 Heraklion, Greece

Department of Applied Science and Technology, Politecnico di Torino, 10129 Turin, Italy

Foundation for Research and Technology Hellas (FO.R.T.H)-IESL, 70013 Heraklion, Greece

Funding

European Union’s Horizon 2020 research and innovation program

References (60)

Show source-provided references
1. Treatment of long bone defects and non-unions: From research to clinical practice10.1007/s00441-011-1184-8 ↗
2. Role of tissue engineering in tendon reconstructive surgery and regenerative medicine: Current concepts, approaches and concerns10.13172/2050-2303-1-2-291 ↗
3. Natural and synthetic polymers/bioceramics/bioactive compounds-mediated cell signalling in bone tissue engineering10.1016/j.ijbiomac.2017.09.029 ↗
4. Zhang, Y., Wu, D., Zhao, X., Pakvasa, M., Tucker, A.B., Luo, H., Qin, K.H., Hu, D.A., Wang, E.J., and Li, A.J. (2020). Stem cell-friendly scaffold biomaterials: Applications for bone tissue engineering and regenerative medicine. Front. Bioeng. Biotechnol., 8.10.3389/fbioe.2020.598607 ↗
5. Recent trends in the application of widely used natural and synthetic polymer nanocomposites in bone tissue regeneration10.1016/j.msec.2020.110698 ↗
6. Georgopoulou, A., Kaliva, M., Vamvakaki, M., and Chatzinikolaidou, M. (2018). Osteogenic potential of pre-osteoblastic cells on a chitosan-graft-polycaprolactone copolymer. Materials, 11.10.3390/ma11040490 ↗
7. Structural and material approaches to bone tissue engineering in powder-based three-dimensional printing10.1016/j.actbio.2010.09.039 ↗
8. Optimization of fused deposition modeling process parameters: A review of current research and future prospects10.1007/s40436-014-0097-7 ↗
9. Additive manufacturing using melt extruded thermoplastics for tissue engineering10.1007/978-1-0716-0611-7_7 ↗
10. Functional aliphatic polyesters for biomedical and pharmaceutical applications10.1016/j.jconrel.2010.12.016 ↗
11. Biocompatibility, biodegradation and excretion of polylactic acid (pla) in medical implants and theranostic systems10.1016/j.cej.2018.01.010 ↗
12. Pla/banana fiber based sustainable biocomposites: A manufacturing perspective10.1016/j.compositesb.2019.107535 ↗
13. Mazzanti, V., Malagutti, L., and Mollica, F. (2019). Fdm 3d printing of polymers containing natural fillers: A review of their mechanical properties. Polymers, 11.10.3390/polym11071094 ↗
14. Investigation of polycaprolactone for bone tissue engineering scaffolds: In vitro degradation and biological studies10.1016/j.matdes.2022.110582 ↗
15. In vitro and in vivo evaluation of polyhydroxybutyrate and of polyhydroxybutyrate reinforced with hydroxyapatite10.1016/0142-9612(91)90072-I ↗
16. Rivera-Briso, A.L., and Serrano-Aroca, Á. (2018). Poly(3-hydroxybutyrate-co-3-hydroxyvalerate): Enhancement strategies for advanced applications. Polymers, 10.10.3390/polym10070732 ↗
17. Hassanajili, S., Karami-Pour, A., Oryan, A., and Talaei-Khozani, T. (2019). Preparation and characterization of pla/pcl/ha composite scaffolds using indirect 3d printing for bone tissue engineering. Mater. Sci. Eng. C Mater. Biol. Appl., 104.10.1016/j.msec.2019.109960 ↗
18. 3d printing of ceramic-based scaffolds for bone tissue engineering: An overview10.1039/C8TB00677F ↗
19. Substituted hydroxyapatite: A recent development10.1080/10667857.2019.1664096 ↗
20. Biodegradable ha-pla 3-d porous scaffolds: Effect of nano-sized filler content on scaffold properties10.1016/j.actbio.2005.06.005 ↗
21. Surface functionalization of 3d printed polymer scaffolds to augment stem cell response10.1016/j.matdes.2018.11.018 ↗
22. Is the calcium receptor a molecular target for the actions of strontium on bone?10.1007/s00198-002-1343-6 ↗
23. Comparison study of biomimetic strontium-doped calcium phosphate coatings by electrochemical deposition and air plasma spray: Morphology, composition and bioactive performance10.1007/s10856-012-4633-3 ↗
24. Effects of strontium ions on growth and dissolution of hydroxyapatite and on bone mineral detection10.1016/S8756-3282(96)00316-X ↗
25. Strontium inhibits osteoclastogenesis by enhancing lrp6 and β-catenin-mediated opg targeted by mir-181d-5p10.1007/s12079-018-0478-y ↗
26. Developing cellular systems in vitro to simulate regeneration10.1089/ten.tea.2014.0002 ↗
27. Co-culture systems of osteoblasts and osteoclasts: Simulating in vitro bone remodeling in regenerative approaches10.1016/j.actbio.2020.03.043 ↗
28. Crosstalk of osteoblast and osteoclast precursors on mineralized collagen—Towards an in vitro model for bone remodeling10.1002/jbm.a.32856 ↗
29. Osteoblast: Osteoclast co-cultures on silk fibroin, chitosan and plla films10.1016/j.biomaterials.2009.07.028 ↗
30. Ascorbic acid promotes osteoclastogenesis from embryonic stem cells10.1016/j.bbrc.2005.08.016 ↗
31. Bone marrow adipocytes support dexamethasone-induced osteoclast differentiation10.1016/j.bbrc.2009.03.111 ↗
32. Beta-glycerophosphate accelerates rankl-induced osteoclast formation in the presence of ascorbic acid
33. Naseem, R., Montalbano, G., German, M.J., Ferreira, A.M., Gentile, P., and Dalgarno, K. (2022). Influence of pcl and phbv on plla thermal and mechanical properties in binary and ternary polymer blends. Molecules, 27.10.3390/molecules27217633 ↗
34. Kontogianni, G.-I., Bonatti, A.F., De Maria, C., Naseem, R., Melo, P., Coelho, C., Vozzi, G., Dalgarno, K., Quadros, P., and Vitale-Brovarone, C. (2023). Promotion of in vitro osteogenic activity by melt extrusion-based plla/pcl/phbv scaffolds enriched with nano-hydroxyapatite and strontium substituted nano-hydroxyapatite. Polymers, 15.10.3390/polym15041052 ↗
35. Processing of sr2+ containing poly l-lactic acid-based hybrid composites for additive manufacturing of bone scaffolds10.3389/fmats.2020.601645 ↗
36. Ficoll-paque versus lymphoprep: A comparative study of two density gradient media for therapeutic bone marrow mononuclear cell preparations10.2217/rme.09.44 ↗
37. Differential expression of cell cycle and wnt pathway-related genes accounts for differences in the growth and differentiation potential of wharton’s jelly and bone marrow-derived mesenchymal stem cells10.1186/s13287-017-0555-9 ↗
38. Heinemann, C., Heinemann, S., Rößler, S., Kruppke, B., Wiesmann, H.P., and Hanke, T. (2019). Organically modified hydroxyapatite (ormohap) nanospheres stimulate the differentiation of osteoblast and osteoclast precursors: A co-culture study. Biomed. Mater., 14.10.1088/1748-605X/ab0fad ↗
39. Kappa-carrageenan/chitosan/gelatin scaffolds enriched with potassium chloride for bone tissue engineering10.1016/j.ijbiomac.2022.04.129 ↗
40. The effects of strontium-substituted bioactive glasses on osteoblasts and osteoclasts in vitro10.1016/j.biomaterials.2010.01.121 ↗
41. Characterization of pluripotent stem cells10.1038/nprot.2012.154 ↗
42. A comparative study of sr-incorporated mesoporous bioactive glass scaffolds for regeneration of osteopenic bone defects10.1007/s00198-014-2735-0 ↗
43. Papadogiannis, F., Batsali, A., Klontzas, M.E., Karabela, M., Georgopoulou, A., Mantalaris, A., Zafeiropoulos, N.E., Chatzinikolaidou, M., and Pontikoglou, C. (2020). Osteogenic differentiation of bone marrow mesenchymal stem cells on chitosan/gelatin scaffolds: Gene expression profile and mechanical analysis. Biomed. Mater., 15.10.1088/1748-605X/aba325 ↗
44. Characterization of peripheral blood mononuclear cells isolated using two kinds of leukocyte filters10.1016/j.tracli.2019.11.001 ↗
45. Tiedemann, K., Le Nihouannen, D., Fong, J.E., Hussein, O., Barralet, J.E., and Komarova, S.V. (2017). Regulation of osteoclast growth and fusion by mtor/raptor and mtor/rictor/akt. Front. Cell Dev. Biol., 5.10.3389/fcell.2017.00054 ↗
46. Bioprinting for bone tissue engineering 3D Print
47. Additive manufacturing approaches for hydroxyapatite-reinforced composites10.1002/adfm.201903055 ↗
48. Comparison of different cell culture plates for the enrichment of non-adherent human mononuclear cells
49. Bone-resorbing osteoclasts reveal a dynamic division of basal plasma membrane into two different domains10.1242/jcs.109.2.301 ↗
50. Strontium ranelate decreases receptor activator of nuclear factor-κb ligand-induced osteoclastic differentiation in vitro: Involvement of the calcium-sensing receptor10.1124/mol.109.063347 ↗
51. Osteogenic and osteoclastogenic differentiation of co-cultured cells in polylactic acid-nanohydroxyapatite fiber scaffolds10.1016/j.jbiotec.2015.03.023 ↗
52. Structure, expression, and regulation of the major noncollagenous matrix proteins of bone10.1097/00003086-199208000-00042 ↗
53. Sparc/osteonectin in mineralized tissue10.1016/j.matbio.2016.02.001 ↗
54. Osteonectin regulates the extracellular matrix mineralization of osteoblasts through p38 signaling pathway10.1002/jcp.29131 ↗
55. opg/rankl: Role and therapeutic target in osteoporosis
56. Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response10.1007/s00198-008-0728-6 ↗
57. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: Involvement of osteoprotegerin10.1016/j.bone.2011.08.031 ↗
58. Dc-stamp is essential for cell-cell fusion in osteoclasts and foreign body giant cells10.1084/jem.20050645 ↗
59. Regulation of nfatc1 in osteoclast differentiation10.11005/jbm.2014.21.4.233 ↗
60. Kruppke, B., Ray, S., Alt, V., Rohnke, M., Kern, C., Kampschulte, M., Heinemann, C., Budak, M., Adam, J., and Döhner, N. (2020). Gelatin-modified calcium/strontium hydrogen phosphates stimulate bone regeneration in osteoblast/osteoclast co-culture and in osteoporotic rat femur defects—In vitro to in vivo translation. Molecules, 25.10.3390/molecules25215103 ↗